Henry Schein Reports Strong Q3 2026 Results and Raises Full-Year EPS Guidance
Henry Schein (HSIC) reported robust third-quarter 2026 financial results, characterized by a 4.0% increase in global net sales to $3.5 billion. The company achieved significant earnings growth, with Non-GAAP diluted EPS rising 13.0% year-over-year to $1.56. Key drivers included strong performance in US Dental Merchandise and Global Technology sales, fueled by cloud-based software adoption. Reflecting confidence in its operational trajectory, management raised its full-year 2026 Non-GAAP diluted EPS guidance to a range of $5.50 to $5.56. While the company noted some macroeconomic headwinds in Brazil and pressure on discretionary dental procedures due to patient out-of-pocket costs, overall margins expanded by 20 basis points, supported by efficiency initiatives and tariff refund benefits.
Tickers: $HSIC
Topics: earnings report EPS guidance financial results revenue growth